Second malignant neoplasms in childhood malignant brain tumour: A long-term population-based study

Journal of Paediatrics and Child Health

Volumn 48, Issue 11, 2012, Pages 990-996

  Cai, Yubo ^a   Cao, Lanfang ^a   Bao, Xuhui ^b,e   Xie, Liyi ^c,d,f  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^d FUDAN UNIVERSITY   (China)

^e DUKE CANCER INSTITUTE   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

children; primary malignant brain tumour; second malignant neoplasm

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; DATA BASE; EPENDYMOMA; FEMALE; FOLLOW UP; GLIOBLASTOMA; HISTOLOGY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDULLOBLASTOMA; NEUROEPITHELIUM; NEWBORN; OVERALL SURVIVAL; POPULATION BASED CASE CONTROL STUDY; PRESCHOOL CHILD; PRIMARY TUMOR; PRIORITY JOURNAL; RACE; SCHOOL CHILD; SECOND MALIGNANT NEOPLASM; SEX DIFFERENCE; STANDARDIZED INCIDENCE RATIO;

ADOLESCENT; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; NEOPLASMS, SECOND PRIMARY; POPULATION SURVEILLANCE; RISK ASSESSMENT; SEX FACTORS; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84868559026     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2012.02583.x     Document Type: Article

References (33)

1. Jemal A, Siegel R, Xu J, et al,. Cancer statistics, 2010. CA Cancer J. Clin. 2010; 60: 277-300.
2. Louis DN, Wiester OD, Ohgaki H, et al,. WHO Classification of Tumours of the Central Nervous System, 4th edn. Lyon: International Agency for Research on Cancer, 2007.
3. Gurney JG, Smith MA, Bunin GR,. CNS and miscellaneous intracranial and intraspinal neoplasms. In:, Ries LAG, Smith MA, Gurney JG, et al., eds. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995, National Cancer Institute, SEER Program. Bethesda, MD: NIH Pub, 1999; 51-64.
4. Schwartzbaum JA, Fisher JL, Aldape KD, et al,. Epidemiology and molecular pathology of glioma. Nat. Clin. Pract. Neurol. 2006; 2: 494-503.
5. Neugut AI, Robinson E, Meadows AT,. Multiple Primary Cancers. Philadelphia: Lippincott Williams & Wilkins, 1999.
6. Neglia JP, Friedman DL, Yasui Y, et al,. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J. Natl. Cancer Inst. 2001; 93: 618-29.
7. Neglia JP, Meadows AT, Robison LL, et al,. Second neoplasms after acute lymphoblastic leukemia in childhood. N. Engl. J. Med. 1991; 325: 1330-6.
8. Strong LC, Stine M, Norsted TL,. Cancer in survivors of childhood soft tissue sarcoma and their relatives. J. Natl. Cancer Inst. 1987; 79: 1213-20.
9. Bhatia S, Robison LL, Oberlin O, et al,. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N. Engl. J. Med. 1996; 334: 745-51.
10. Gray RJ,. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann. Stat. 1988; 16: 1141-54.
11. Fine JP, Gray RJ,. A proportional hazards model for the subdistribution of a competing risk. J. Am. Stat. Assoc. 1999; 94: 496-509.
12. Bondy ML, EI-Zein R, Scheurer ME,. Epidemiology of brain tumors. In:, DeMonte F, Gilbert MR, Mahajan A, eds. Tumors of the Brain and Spine. M. D. Anderson Cancer care series. New York: Springer, 2007; 1-22.
13. Kufe DW, Frei E, Holland JF,. Cancer Medicine 7, 7th edn. Hamilton; London: Elsevier, 2006.
14. Mueller S, Chang S,. Pediatric brain tumors: current treatment strategies and future therapeutic approaches. Neurother. 2009; 6: 570-86.
15. Kleinerman RA,. Radiation-sensitive genetically susceptible pediatric sub-populations. Pediatr. Radiol. 2009; 39 (Suppl. 1): S27-31.
16. Relling MV, Rubnitz JE, Rivera GK, et al,. High incidence of secondary brain tumours after radiotherapy and antimetabolites. Lancet 1999; 354: 34-9.
17. Hawkins MM, Wilson LM, Burton HS, et al,. Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J. Natl. Cancer Inst. 1996; 88: 270-8.
18. Bhatia S, Sklar C,. Second cancers in survivors of childhood cancer. Nat. Rev. Cancer 2002; 2: 124-32.
19. Duffner PK, Cohen ME, Thomas PR, et al,. The long-term effects of cranial irradiation on the central nervous system. Cancer 1985; 56: 1841-6.
20. Neglia JP, Robison LL, Stovall M, et al,. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J. Natl. Cancer Inst. 2006; 98: 1528-37.
21. Duffner PK, Horowitz ME, Krischer JP, et al,. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N. Engl. J. Med. 1993; 328: 1725-31.
22. Freeman CR, Farmer J, Taylor RE,. Central nervous system tumors in children. In:, Halperin EC, Perez CA, Brady LW, eds. Perez and Brady's Principles and Practice of Radiation Oncology, 5th edn. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2008; 1822-49.
23. Bernier J, Hall EJ, Giaccia A,. Radiation oncology: a century of achievements. Nat. Rev. Cancer 2004; 4: 737-47.
24. Marks LB, Ma J,. Challenges in the clinical application of advanced technologies to reduce radiation-associated normal tissue injury. Int. J. Radiat. Oncol. Biol. Phys. 2007; 69: 4-12.
25. Hall EJ,. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int. J. Radiat. Oncol. Biol. Phys. 2006; 65: 1-7.
26. Hall EJ, Wuu CS,. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int. J. Radiat. Oncol. Biol. Phys. 2003; 56: 83-8.
27. Greene MH, Boice JD Jr, Strike TA,. Carmustine as a cause of acute nonlymphocytic leukemia. N. Engl. J. Med. 1985; 313: 579.
28. Neyns B, Cordera S, Joosens E, et al,. Non-Hodgkin's lymphoma in patients with glioma treated with temozolomide. J. Clin. Oncol. 2008; 26: 4518-19.
29. Sharma A, Gupta D, Mohanti BK, et al,. Non-Hodgkin lymphoma following temozolomide. Pediatr. Blood Cancer 2009; 53: 661-2.
30. Peterson KM, Shao C, McCarter R, et al,. An analysis of SEER data of increasing risk of secondary malignant neoplasms among long-term survivors of childhood brain tumors. Pediatr. Blood Cancer 2006; 47: 83-8.
31. Devarahally SR, Severson RK, Chuba P, et al,. Second malignant neoplasms after primary central nervous system malignancies of childhood and adolescence. Pediatr. Hematol. Oncol. 2003; 20: 617-25.
32. Pizer B, May P,. Paediatric surgical oncology. 8-central nervous system tumours in children. Eur. J. Surg. Oncol. 1997; 23: 559-64.
33. Pollack IF,. Brain tumors in children. N. Engl. J. Med. 1994; 331: 1500-7.